Spironolactone in Patients on Chronic Haemodialysis at High Risk of Adverse Cardiovascular Outcomes (Alchemist) : a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial and Updated Meta-Analysis
AuthID
P-019-VCT
P-019-VCT